Skip to main content
SpringerLink
Log in

Fungal Pneumonia

Fever and Dry Cough After Visiting or Living in an Endemic Area

  • Chapter
  • First Online:
Introduction to Clinical Infectious Diseases

  • 2024 Accesses

Abstract

Fungal pneumonia is a rare but often serious infective process that may complicate or be indicative of an underlying immune deficiency. Molds and dimorphic fungi can both cause pulmonary disease, while yeast is nearly always a commensal organism. Efforts to identify and treat the specific fungal pathogen can be a difficult process that involves all facets of clinical medicine. Treatment is targeted to the suspected or proven pathogen, and newer antifungal agents such as the broad-spectrum triazoles and the echinocandins provide better tolerated alternatives to the traditional amphotericin B, although with narrower spectrums of activity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984;100(3):345–51.

    Article  CAS  Google Scholar 

  2. Abers MS, Ghebremichael MS, Timmons AK, Warren HS, Poznansky MC, Vyas JM. A critical reappraisal of prolonged neutropenia as a risk factor for invasive pulmonary aspergillosis. Open Forum Infect Dis. 2016;3(1):ofw036.

    Article  Google Scholar 

  3. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–34.

    Article  Google Scholar 

  4. Petrikkos G, Drogari-Apiranthitou M. Zygomycosis in Immunocompromised non-haematological patients. Mediterr J Hematol Infect Dis. 2011;3(1):e2011012.

    Article  Google Scholar 

  5. Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, et al. Histoplasmosis complicating tumor necrosis factor-alpha blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015;61(3):409–17.

    Article  Google Scholar 

  6. Tragiannidis A, Kyriakidis I, Zundorf I, Groll AH. Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-alpha) inhibitors. Mycoses. 2017;60(4):222–9.

    Article  CAS  Google Scholar 

  7. Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57(4):e22–e121.

    Article  Google Scholar 

  8. Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the twenty-first century. Clin Microbiol Rev. 2011;24(2):247–80.

    Article  Google Scholar 

  9. Kozel TR, Wickes B. Fungal diagnostics. Cold Spring Harb Perspect Med. 2014;4(4):a019299.

    Article  Google Scholar 

  10. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42(10):1417–27.

    Article  CAS  Google Scholar 

  11. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2005;43(12):5957–62.

    Article  CAS  Google Scholar 

  12. Hage CA, Ribes JA, Wengenack NL, Baddour LM, Assi M, McKinsey DS, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53(5):448–54.

    Article  Google Scholar 

  13. Ampel NM. The diagnosis of coccidioidomycosis. F1000 Med Rep. 2010;2:2.

    PubMed  PubMed Central  Google Scholar 

  14. Frost HM, Novicki TJ. Blastomyces Antigen Detection for Diagnosis and Management of Blastomycosis. J Clin Microbiol. 2015;53(11):3660–2.

    Article  CAS  Google Scholar 

  15. Hage CA, Knox KS, Davis TE, Wheat LJ. Antigen detection in bronchoalveolar lavage fluid for diagnosis of fungal pneumonia. Curr Opin Pulm Med. 2011;17(3):167–71.

    Article  CAS  Google Scholar 

  16. Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, Catanzaro A, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183(1):96–128.

    Article  CAS  Google Scholar 

  17. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63(4):e1–e60.

    Article  Google Scholar 

  18. Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Bruggemann RJ, Chowdhary A, et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resist Updat. 2015;21–22:30–40.

    Article  Google Scholar 

  19. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20(4):695–704.

    Article  CAS  Google Scholar 

  20. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20(Suppl 3):5–26.

    Article  CAS  Google Scholar 

  21. Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, et al. Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis. J Antimicrob Chemother. 2015;70(11):3116–23.

    Article  CAS  Google Scholar 

  22. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807–25.

    Article  Google Scholar 

  23. Assi M, Martin S, Wheat LJ, Hage C, Freifeld A, Avery R, et al. Histoplasmosis after solid organ transplant. Clin Infect Dis. 2013;57(11):1542–9.

    Article  CAS  Google Scholar 

  24. Freifeld A, Proia L, Andes D, Baddour LM, Blair J, Spellberg B, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother. 2009;53(4):1648–51.

    Article  CAS  Google Scholar 

  25. Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, Queiroz-Telles F, Ostrosky-Zeichner L, Azie N, et al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016;63(3):356–62.

    Article  CAS  Google Scholar 

  26. Chapman SW, Dismukes WE, Proia LA, Bradsher RW, Pappas PG, Threlkeld MG, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(12):1801–12.

    Article  CAS  Google Scholar 

  27. Proia LA, Harnisch DO. Successful use of posaconazole for treatment of blastomycosis. Antimicrob Agents Chemother. 2012;56(7):4029.

    Article  CAS  Google Scholar 

  28. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112–46.

    Article  Google Scholar 

  29. Woosley RaR, KA. www.crediblemeds.org [QTdrugs List].

  30. Niwa T, Imagawa Y, Yamazaki H. Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450. Curr Drug Metab. 2014;15(7):651–79.

    Article  CAS  Google Scholar 

  31. Girmenia C, Iori AP. Safety and interactions of new antifungals in stem cell transplant recipients. Expert Opin Drug Saf. 2012;11(5):803–18.

    Article  CAS  Google Scholar 

  32. Flockhart DA. Drug interactions: cytochrome P450 drug interaction table Indiana University School of Medicine 2007 [Available from: http://medicine.iupui.edu/clinpharm/ddis/main-table/].

Download references

Author information

Authors and Affiliations

  1. Connecticut Children’s Medical Center, Division of Infectious Diseases and Immunology, Hartford, CT, USA

    Thomas S. Murray & Nicholas J. Bennett

  2. University of Connecticut/Connecticut Children’s Medical Center, Pharmacy Practice/Infectious Diseases, Hartford, CT, USA

    Jennifer Ellis Girotto

Authors
  1. Thomas S. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Ellis Girotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicholas J. Bennett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicholas J. Bennett .

Editor information

Editors and Affiliations

  1. SUNY Upstate Medical University, Syracuse, NY, USA

    Joseph Domachowske

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Murray, T.S., Girotto, J.E., Bennett, N.J. (2019). Fungal Pneumonia. In: Domachowske, J. (eds) Introduction to Clinical Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-91080-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91080-2_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91079-6

  • Online ISBN: 978-3-319-91080-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation